CGY Calian Group Ltd

Calian Completes $69 Million Upsized Bought Deal Public Offering

Calian Completes $69 Million Upsized Bought Deal Public Offering

NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

OTTAWA, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Calian Group Ltd. (“Calian” or the “Company”) (TSX:CGY) is pleased to announce that it has completed its previously announced upsized bought deal offering, under which a total of 1,568,600 common shares of Calian (the "Common Shares") were sold at a price of $44.00 per Common Share for aggregate gross proceeds of $69,018,400, including Common Shares issued pursuant to the exercise in full of the over-allotment option granted to the Underwriters (as defined below) (the "Offering"). The Offering was conducted by a syndicate of underwriters led by Desjardins Capital Markets and including Acumen Capital Finance Partners Limited, Canaccord Genuity Corp., Stifel Nicolaus Canada Inc., TD Securities Inc. and RBC Dominion Securities Inc. (collectively, the “Underwriters”).

The Company intends to use the net proceeds from the Offering to, among other things and as more fully described in the Prospectus Supplement (as defined below), pursue strategic growth initiatives and for general corporate purposes.

The Common Shares were offered (i) by way of a prospectus supplement dated February 18, 2020 (the “Prospectus Supplement”) to Calian’s short form base shelf prospectus dated January 31, 2020, which Prospectus Supplement was filed with the securities commissions and other similar regulatory authorities in each of the provinces of Canada; (ii) in the United States by way of private placement pursuant to the exemption from registration provided for under Rule 144A of the United States Securities Act of 1933, as amended; and (iii) in jurisdictions outside of Canada and the United States as agreed to by the Company and the Underwriters on a private placement or equivalent basis.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been registered under the U.S. Securities Act of 1933, as amended, and applicable U.S. state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements thereunder.

About Calian

Calian employs over 3,400 people in its delivery of diverse products and solutions for private sector, government and defence customers in North American and global markets. The Company’s diverse capabilities are delivered through four segments: Advanced Technologies, Health, Learning and Information Technology. The Advanced Technologies segment provides innovative products, technologies and manufacturing services and solutions for the space, communications, defence, nuclear, government and agriculture sectors. The Health segment manages a network of more than 1,800 health care professionals delivering primary care and occupational health services to public and private sector clients across Canada. Learning is a trusted provider of emergency management, consulting and specialized training services and solutions for the Canadian Armed Forces and clients in the defence, health, energy and other sectors. The Information Technology segment supports public- and private-sector customer requirements for subject matter expertise in the delivery of complex IT and cyber security solutions. Headquartered in Ottawa, the Company’s offices and projects span Canada and international markets.

For investor information, please visit Calian’s website at or contact the Company at .

Kevin Ford  Patrick Houston  Simon Doyle
President and Chief Executive Officer     Chief Financial Officer     Media inquiries: 
613-599-8600    613-599-8600  613-599-8600 x 2205

Forward-Looking Statements

This press release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur and include, but are not to, statements regarding the proposed use of the net proceeds under the Offering. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this press release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry, the potential offering of any securities by the Company; uncertainty with respect to the completion of any future offering; the ability to obtain applicable regulatory approval for any contemplated offerings; the ability of the Company to negotiate and complete future funding transactions, as well as the risks identified under the heading “Risk Factors” in the Company’s Annual Information Form for its fiscal year ended September 30, 2019. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

EN
25/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Calian Group Ltd

 PRESS RELEASE

Calian Announces the Appointment of New President of Advanced Technolo...

Calian Announces the Appointment of New President of Advanced Technologies OTTAWA, March 27, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, is pleased to appoint Valérie Travain-Milone as President, Advanced Technologies (AT). Travain-Milone brings extensive leadership experience across GNSS, telecom, space, cybersecurity and digital services. Known for her purpose-driven approach and passion for technology, she has consistently nurtured teams towards suc...

 PRESS RELEASE

Calian to Deliver Spectrum Interference Simulation Technology for the ...

Calian to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency OTTAWA, March 21, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions has won a contract with the Canadian Space Agency (CSA) to develop a spectrum interference simulation solution. Calian’s spectrum interference simulation software will help the CSA coordinate frequency for the ongoing shared use of valuable Radio Frequency (RF) spectrum. This support will sustain the C...

 PRESS RELEASE

Calian Strengthens Nuclear Capability with Acquisition of MDA Ltd. Nuc...

Calian Strengthens Nuclear Capability with Acquisition of MDA Ltd. Nuclear Assets OTTAWA, March 05, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, and MDA Ltd (TSX:MDA), a trusted global mission partner, have completed a transaction in which Calian has purchased assets associated with MDA’s nuclear services. MDA has provided professional services to the Canadian nuclear industry for more than 30 years, supported by a highly specialized team of enginee...

 PRESS RELEASE

Calian renforce sa capacité nucléaire avec l’acquisition des actifs nu...

Calian renforce sa capacité nucléaire avec l’acquisition des actifs nucléaires de MDA Ltd. OTTAWA, 05 mars 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), une société de solutions diversifiées qui fournit des produits et des services innovants dans les domaines de la santé, des communications, de l’apprentissage et de la cybersécurité, et MDA Ltd (TSX:MDA), un partenaire de confiance pour les missions internationales, ont conclu une transaction dans laquelle Calian a acheté des actifs associés aux services nucléaires de MDA. MDA fournit des services professionnels à l’industrie ...

 PRESS RELEASE

Calian Wins Contract to Support Clinical Trial for ZYUS Life Sciences’...

Calian Wins Contract to Support Clinical Trial for ZYUS Life Sciences’ Lead Drug Product Candidate OTTAWA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions has won a contract to support a Phase 2 Clinical Trial of ZYUS Life Science’s Trichomylin® softgel capsules in patients with advanced cancer and moderate to severe cancer-related pain. Calian's full-service Contract Research Organization (CRO) will apply its extensive clinical trial management ex...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch